US breakthrough in prevention of PRRS Virus
MJ Biologics, in conjunction with the University of Minnesota, announces a
breakthrough in the control and prevention of porcine reproductive and
respiratory syndrome disease (PRRS), a devastating disease of pigs
Research conducted by MJ Biologics and the University has led to the decoding
of the PRRS virus and the development of a
new inactivated subunit vaccine.
Patent-pending Selectigen MJPRRSâ„¢ technology now offers
veterinarians and swine producers a new tool in the ongoing battle against the
PRRS virus. By breaking the genetic code of the PRRS virus, MJPRRS technology
allows the production of autogenous vaccines that are tailored to each unique
swine production system.
This technology utilizes an innovative method
of classifying PRRS viruses based on their immunological properties, allowing
for the creation of new custom vaccines as a tool against intra-farm mutations.
In addition, the enhanced cross-protection capability helps to reduce financial
losses from new strains introduced into the farm.
In pregnant sow control studies conducted by independent
veterinarians and the University, the MJPRRS vaccine provided excellent cross
protection against heterologous strains of PRRS virus.
"By using the
vaccine in herds with a history of PRRS virus, we have been able to prevent
prenatal losses while stabilizing the herds and simultaneously protecting the
sow population against clinical disease outbreaks from 'new' virus strains
entering the herd," said Dr. Paul Armbrecht of Lake City Veterinary Service in
Lake City, Iowa.
Many veterinarians and
swine producers have already experienced the value of the MJPRRS vaccine.
According to Dr. Mark Fitzsimmons, recipient of the 2006 Swine Practitioner of
the Year, "MJPRRS technology appears to be one of the biggest breakthroughs in
disease control across the swine industry in the last 10 years. Finally we have
some light at the end of the tunnel in controlling and preventing this
â€¢ MJ Biologics
to the free Pig Progress newsletter
To comment, login here
Or register to be able to comment.